¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pulmonary flow resistance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • pulmonary ventilation
    Æóȯ±â
  • pulmonary ventilatory capacity
    Æóȯ±â¿ë·®
  • right pulmonary artery
    ¿À¸¥ÇãÆÄµ¿¸Æ, ¿ìÆóµ¿¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • streamline flow
    À¯¼±ÇüÈ帧
  • sublayer flow
    ÀúÃþ·ù, ¹ØÃþ·ù
  • turbulent flow
    ¼Ò¿ëµ¹ÀÌÈ帧, ¿Í·ù
  • gas flow meter
    ±âüÀ¯¼Ó°è
  • high flow method
    °íÀ¯·®¹ý
  • maximal midexpiratory flow rate
    ÃÖ´ëÁß°£³¯¼ûÀ¯¼Ó
  • maximum expiratory flow rate
    Ãִ볯¼ûÀ¯·®·ü
  • maximum flow rate
    ÃÖ´ë¿ä¼Ó
  • peak flow meter
    ÃÖ´ëÀ¯·®°è, ÃÖ°íÀ¯·®°è
  • quantitative flow measurement
    Á¤·®À¯·®ÃøÁ¤
  • stop flow method
    È帧Á¤Áö¹ý, À¯ÅëÁ¤Áö¹ý
  • peak expiratory flow rate
    ÃÖ°í³¯¼û·ù·®
  • peak flow rate
    ÃÖ°íÀ¯¼Ó, ÃÖ°í±â·ù·®
  • pressure flow study
    ¾Ð·Â¿ä·ù°Ë»ç
  • ventilation blood flow ratio
    ȯ±âÇ÷·ùºñÀ²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • pulmonary edema
    ÆóºÎÁ¾(øËÝ©ðþ)
  • pulmonary edema
    ÆóºÎÁ¾
  • pulmonary embolectomy
    Æóµ¿¸Æ»öÀüÀûÃâ(¼ú)(¡­î×õóâú).
  • pulmonary embolism
    Æó(µ¿¸Æ)»öÀüÁõ(¡­ßáîûñø).
  • pulmonary embolism
    Æó(µ¿¸Æ)»öÀüÁõ(øË(ÔÑØæ)ßáîûñø)
  • pulmonary embolism
    Æó»öÀüÁõ
  • pulmonary emphysema
    Æó±âÁ¾(øËѨðþ).
  • pulmonary emphysema
    Æó±âÁ¾(øËѨðþ)
  • pulmonary eosinophilia
    ÆóÈ£»ê±¸Áõ°¡(Áõ)(øËû¿ß«Ï¹ñòÊ¥(ñø)), ÆóÈ£»ê±¸Áõ´Ù(Áõ)(øËû¿ß«Ï¹ñòÒý(ñø))
  • pulmonary epithelial cell
    Æó»óÇǼ¼Æ÷(øËß¾ù«á¬øà).
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø).
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø)
  • pulmonary fibrosis
    Æó¼¶À¯È­
  • pulmonary function test
    Æó±â´É°Ë»ç (¡­ËþÞÛ).
  • pulmonary glomus
    ÇãÆÄµ¿¸ÆÅ丮
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • flow cytometer
    À¯½Ä¼¼Æ÷ÃøÁ¤±â
  • flow cytometry
    À¯½Ä¼¼Æ÷ÃøÁ¤
  • flow cytometry
    À¯¼¼Æ÷ºÐ¼®
  • flow cytometry
    È긲¼¼Æ÷°èÃø¹ý
  • flow cytometry
    À¯½Ä¼¼Æ÷ÃøÁ¤±â
  • flow cytometry
    À¯·®¼¼Æ÷°è»ê
  • flow cytometry
    À¯¼Ó ¼¼Æ÷ºÐ¼®¹ý
  • flow encoding axis
    À¯µ¿ ºÎȣȭ Ãà
  • flow meter
    À¯·®(êüÕá)<À¯¼Ó(êüáÜ)>°è(Ìþ).
  • flow meter
    À¯·®<À¯¼Ó>°è.
  • flow meter controlled vaporizer
    À¯·®Á¶Àý±âÈ­±â.
  • flow misregistration
    À¯µ¿ ¿Àµî·Ï
  • flow phenomena
    À¯µ¿ Çö»ó
  • flow rate
    À¯¼Ó
  • flow related enhancement
    À¯µ¿ °ü·Ã Áõ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
CPE cardiac pulmonary edema; chronic pulmonary emphysema; clinical progress exercise; compensation, pens...
IPF idiopathic pulmonary fibrosis; infection-potentiating factor; interstitial pulmonary fibrosis
IPH idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio...
PACP pulmonary alveolar-capillary permeability; pulmonary artery counterpulsation
PAGOD pulmonary hypoplasia-hypoplasia of pulmonary artery-agonadism-omphalocele/diaphragmatic defect-dextr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
ouar Ouabain resistance
PR Peripheral resistance
PVR Peripheral vascular resistance
RVR Renal vascular resistance
RVR Renovascular resistance
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
pulmonary collapse Secondary atelectasis due to bronchial obstruction, pleural effusion or pneumothorax, cardiac hypertrophy, or enlargement of other structures adjacent to the lungs.
(05 Mar 2000)
pulmonary cone The left or anterosuperior, smooth-walled portion of the cavity of the right ventricle of the heart, which begins at the supraventricular crest and terminates in the pulmonary trunk.
Synonym: arterial cone, pulmonary cone, pulmonary conus.
(05 Mar 2000)
pulmonary conus The left or anterosuperior, smooth-walled portion of the cavity of the right ventricle of the heart, which begins at the supraventricular crest and terminates in the pulmonary trunk.
Synonym: arterial cone, pulmonary cone, pulmonary conus.
(05 Mar 2000)
pulmonary diffusing capacity The ability of the alveolocapillary membrane to transfer gas. This is a reflection of the thinness and area of the alveolocapillary membrane. The diffusing capacity is a measure of the amount of gas transferred per minute from the alveolar gas to the pulmonary capillary blood divided by the mean pressure gradient of the gas between the alveolar gas and the capillary blood.
(12 Dec 1998)
pulmonary disease (specialty) A subspecialty of internal medicine concerned with the study of the respiratory system. It is especially concerned with diagnosis and treatment of diseases and defects of the lungs and bronchial tree.
(12 Dec 1998)
pulmonary distomiasis Infection with trematodes of the genus paragonimus.
(12 Dec 1998)
pulmonary dysmaturity syndrome <syndrome> A respiratory disorder occurring in small, premature infants who are incapable of normal pulmonary ventilation and who often die of hypoxia after an illness of 6 to 8 weeks; the lungs contain widespread focal emphysematous blebs and the parenchyma has thickened alveolar walls; diagnosed principally on the basis of the clinical history, chest radiographic findings, and the findings at autopsy, which must include the absence of pathological changes characteristic of other pulmonary disorders commonly encountered in this age group.
Synonym: Wilson-Mikity syndrome.
(05 Mar 2000)
pulmonary embolism <cardiology> The lodgment of a blood clot in the lumen of a pulmonary artery, causing a severe dysfunction in respiratory function.
Pulmonary emboli often have origin in the veins of the lower extremities where clots form in the deep leg veins and then travel to the lungs via the venous circulation.
Symptoms and features include acute onset of shortness of breath, chest pain (worse with breathing) and rapid heart rate and respiratory rate. Some individuals may have haemoptysis.
Diagnosis can be made on a ventilation perfusion scan of the lung or on a pulmonary angiogram.
(15 Dec 1997)
pulmonary embolism: findings <radiology> Embolism without infarction (90%), normal chest (25%), platelike atelactasis, Westermark sign, knuckle sign, local widening of artery by impacted embolus, segmental / lobar consolidation, pleural effusion embolism with infarction (10%), wedge-shaped consolidation (50%), may cavitate, Hampton hump, pleural effusion (50%), no air-bronchogram, melting sign, Fleischner lines, platelike atelactasis (25%), cardiomegaly / congestive heart failure (20%), elevated hemidiaphragm (20%) see: pulmonary embolism
(12 Dec 1998)
pulmonary emphysema Condition of the lungs characterised by increase beyond normal in the size of air spaces distal to the terminal bronchioles, either from dilatation of the alveoli or from destruction of their walls.
(12 Dec 1998)
pulmonary encephalopathy Coma seen with advanced lung failure and resultant hypoventilation.
Synonym: CO2 narcosis, hypoxic-hypercarbic encephalopathy, pulmonary encephalopathy.
(05 Mar 2000)
pulmonary eosinophilia A disease characterised by pulmonary infiltrations of eosinophils and blood eosinophilia.
(12 Dec 1998)
pulmonary fibrosis Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure.
(12 Dec 1998)
pulmonary fistula A parietal fistula communicating with the lung.
(05 Mar 2000)
pulmonary gas exchange The exchange of oxygen and carbon dioxide between alveolar air and pulmonary capillary blood.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á